Alexander A. Fitzpatrick's most recent trade in ARS Pharmaceuticals Inc was a trade of 152,300 Stock option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
ARS Pharmaceuticals Inc | Alexander A. Fitzpatrick | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 152,300 | 152,300 | - | - | Stock option (right to buy) | |
ARS Pharmaceuticals Inc | Alexander A. Fitzpatrick | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 300,000 | 300,000 | - | - | Stock option (right to buy) | |
ARS Pharmaceuticals Inc | Alexander A. Fitzpatrick | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 700,000 | 700,000 | - | - | Stock option (right to buy) |